Rituximab (anti-CD20)

Product Name：  Rituximab

CAS No.:    174722-31-7                            

Formula:    C₆₄₁₆H₉₈₇₄N₁₆₈₈O₁₉₈₇S₄₄                         

Molecular Weight：     145 kDa               

Type:     Whole antibody                    

Target：  CD20
Antibody Form: Purified immunoglobulin
Physical Form:  Solution
Storage:  -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light.
Description

Rituxan® (rituximab) is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab has an approximate molecular weight of 145 kD. Rituximab is produced by mammalian cell (Chinese Hamster Ovary) suspension culture in a nutrient medium containing the antibiotic gentamicin. Gentamicin is not detectable in the final product.

Biological Activity
Rituximab (anti-CD20) is a chimeric anti-CD20 mAb that binds the CD20 antigen on B cells with a binding affinity of 5 nM

For research use only. Not for use in humans